Interferon associated retinopathy.
作者信息
Hayasaka S, Nagaki Y, Matsumoto M, Sato S
机构信息
Department of Ophthalmology, Toyama Medical and Pharmaceutical University, Japan.
出版信息
Br J Ophthalmol. 1998 Mar;82(3):323-5. doi: 10.1136/bjo.82.3.323.
Abstract
摘要
相似文献
1
Interferon associated retinopathy.干扰素相关性视网膜病变
Br J Ophthalmol. 1998 Mar;82(3):323-5. doi: 10.1136/bjo.82.3.323.
2
Interferon associated retinopathy.干扰素相关性视网膜病变
J Pak Med Assoc. 2008 Jan;58(1):48-9.
3
[A case report of interferon-associated retinopathy].[一例干扰素相关性视网膜病变的病例报告]
Klin Oczna. 1999;101(3):213-6.
4
Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C.聚乙二醇干扰素和利巴韦林相关视网膜病变导致一名慢性丙型肝炎患者永久性视力损害
Ophthalmic Surg Lasers Imaging. 2011 Sep 8;42 Online:e91-3. doi: 10.3928/15428877-20110901-07.
5
[Ocular findings in hepatitis C patients treated with interferon].[接受干扰素治疗的丙型肝炎患者的眼部表现]
Klin Oczna. 2010;112(7-9):253-6.
6
Hepatitis C and interferon-associated retinopathy: a case report.丙型肝炎与干扰素相关性视网膜病变：一例报告
Optometry. 2011 Dec;82(12):739-43. doi: 10.1016/j.optm.2010.11.016.
7
[Interferon-associated retinopathy].[干扰素相关性视网膜病变]
Nihon Rinsho. 1994 Jul;52(7):1919-23.
8
Blurred vision: cause? Retinopathy secondary to interferon treatment.视力模糊：病因？继发于干扰素治疗的视网膜病变。
Gut. 2006 Feb;55(2):211, 251. doi: 10.1136/gut.2005.068833.
9
Interferon-induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection.干扰素诱导的视网膜病变及其在慢性丙型肝炎病毒感染治疗的糖尿病和高血压患者中的风险。
Aliment Pharmacol Ther. 2009 Sep 15;30(6):597-602. doi: 10.1111/j.1365-2036.2009.04071.x. Epub 2009 Jun 22.
10
A case of successful treatment of a rare retinal disease presented by interferon-induced retinopathy.一例由干扰素诱导的视网膜病变引起的罕见视网膜疾病的成功治疗案例。
Wiad Lek. 2024;77(3):491-496. doi: 10.36740/WLek202403117.
引用本文的文献
1
Discovering potential pathways between type 2 diabetes mellitus and diabetic retinopathy: A big data analysis of the South Korean National Sample Cohort.探索 2 型糖尿病与糖尿病视网膜病变之间的潜在途径：基于韩国国家样本队列的大数据分析。
Medicine (Baltimore). 2023 Aug 4;102(31):e34576. doi: 10.1097/MD.0000000000034576.
2
Topical interferon - A novel treatment for pseudophakic macular edema.局部应用干扰素治疗后房型黄斑水肿的研究进展。
Indian J Ophthalmol. 2021 Sep;69(9):2355-2360. doi: 10.4103/ijo.IJO_2704_20.
3
Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin.聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎病毒感染患者不同类型干扰素相关性视网膜病变的分析。
Viruses. 2021 Mar 14;13(3):475. doi: 10.3390/v13030475.
4
A Drop in Hemoglobin as an Association with Pegylated Interferon Retinopathy: A Novel Pathophysiology.血红蛋白下降与聚乙二醇化干扰素视网膜病变的关联：一种新的病理生理学。
J Curr Ophthalmol. 2020 Apr 30;32(2):195-198. doi: 10.4103/JOCO.JOCO_103_20. eCollection 2020 Apr-Jun.
5
Association of Ledipasvir-Sofosbuvir Treatment With Uveitis in Patients Treated for Hepatitis C.聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎致贫血的相关因素分析
JAMA Ophthalmol. 2019 May 1;137(5):568-570. doi: 10.1001/jamaophthalmol.2019.0374.
6
The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis.用于治疗多发性硬化症的药物的眼部表现。
Drugs. 2017 Mar;77(3):303-311. doi: 10.1007/s40265-017-0692-6.
7
The efficacy of intravitreal interferon alpha-2b for the treatment of experimental endotoxin-induced uveitis.玻璃体内注射干扰素α-2b治疗实验性内毒素诱导性葡萄膜炎的疗效
Indian J Ophthalmol. 2016 May;64(5):376-81. doi: 10.4103/0301-4738.185605.
8
Interferon-β Inhibits Neurotrophin 3 Signalling and Pro-Survival Activity by Upregulating the Expression of Truncated TrkC-T1 Receptor.干扰素-β通过上调截短型TrkC-T1受体的表达来抑制神经营养因子3信号传导和促生存活性。
Mol Neurobiol. 2017 Apr;54(3):1825-1843. doi: 10.1007/s12035-016-9789-2. Epub 2016 Feb 18.
9
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature.多发性硬化症患者接受β-干扰素治疗期间的视网膜病变：病例报告及文献综述
J Neurol. 2016 Mar;263(3):422-7. doi: 10.1007/s00415-015-7879-0. Epub 2015 Aug 21.
10
Drug-induced macular edema.药物性黄斑水肿。
Drugs. 2013 Jun;73(8):789-802. doi: 10.1007/s40265-013-0055-x.
本文引用的文献
1
Virus interference. I. The interferon.病毒干扰。一、干扰素。
Proc R Soc Lond B Biol Sci. 1957 Sep 12;147(927):258-67. doi: 10.1098/rspb.1957.0048.
2
Local interferon alfa-2b for ocular cicatricial pemphigoid.局部使用干扰素α-2b治疗瘢痕性类天疱疮性睑球粘连。
Br J Ophthalmol. 1996 Oct;80(10):927. doi: 10.1136/bjo.80.10.927.
3
Clinical characteristics of hepatitis C virus-associated retinopathy.丙型肝炎病毒相关性视网膜病变的临床特征。
Jpn J Ophthalmol. 1995;39(4):411-9.
4
[Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis].[丙型慢性活动性肝炎患者干扰素相关性视网膜病变危险因素的评估]
Nippon Ganka Gakkai Zasshi. 1996 Jan;100(1):69-76.
5
Interferon-associated retinopathy.干扰素相关性视网膜病变
Arch Ophthalmol. 1993 Mar;111(3):350-6. doi: 10.1001/archopht.1993.01090030068041.
6
Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.α-2a干扰素治疗年龄相关性黄斑变性的中心凹下新生血管形成
Ophthalmology. 1993 Sep;100(9):1417-24. doi: 10.1016/s0161-6420(93)31467-3.
7
Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa.接受干扰素α治疗的慢性病毒性肝炎患者的视网膜病变和结膜下出血
Br J Ophthalmol. 1995 Feb;79(2):150-2. doi: 10.1136/bjo.79.2.150.
8
Regression of experimental iris neovascularization with systemic alpha-interferon.全身性α-干扰素使实验性虹膜新生血管消退
Ophthalmology. 1993 Jan;100(1):9-14. doi: 10.1016/s0161-6420(93)31712-4.
9
[Interferon-induced retinal changes].[干扰素诱导的视网膜变化]
Nippon Ganka Gakkai Zasshi. 1994 Jun;98(6):616-21.
10
Recombinant leukocyte A interferon in Kaposi's sarcoma.重组白细胞A干扰素治疗卡波西肉瘤
Ann N Y Acad Sci. 1984;437:431-8. doi: 10.1111/j.1749-6632.1984.tb37164.x.
Zotero 插件